Kwon, S.U., Cho, Y.-J., Koo, J.-S., Bae, H.-J., Lee, Y.-S., Hong, K.-S., Lee, J.H. and Kim, J.S. (2005) Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis: The Multicenter Double-Blind Placebo-Controlled Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis. Stroke, 36, 782-786.
http://dx.doi.org/10.1161/01.STR.0000157667.06542.b7

has been cited by the following article:

• TITLE: Intracranial Atherosclerosis: The Natural History and Management Strategies

  AUTHORS: Ossama Mansour, Martin Schumacher, Mohammad A. Farrag, Foad Abd-Allah

  KEYWORDS: Intracranial Atherosclerosis, Medical Therapy, Endovascular Treatment

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.4 No.7, June 12, 2014

  ABSTRACT: Intracranial atherosclerotic disease (ICAD) represents a major cause of stroke and transient ischemic attacks. The prevalence and natural course of ICAD are closely related to race and ethnicity. The best treatment for ICAD is a crucial issue; data from recent trials indicate that aggressive medical management and life style modifications are better than endovascular treatments for prevention of recurrent stroke in high-risk patients with ICAD. Endovascular treatment is still an option for subgroup of patients who are not responded to optimal medical therapy.